BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 5 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 5 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 5 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 6 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 6 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 7 hours ago Atmus Welcomes Heath Sharp to Board of Directors 9 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 9 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 5 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 5 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 5 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 6 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 6 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 7 hours ago Atmus Welcomes Heath Sharp to Board of Directors 9 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 9 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago
ADVERTISEMENT
AlphaGraphs

Crawford & Company (CRD-A, CRD-B) Earnings: 3Q23 Key Numbers

Crawford & Company (NYSE: CRD-A, CRD-B) reported revenues before reimbursements of $325.6 million for the third quarter of 2023, up 10% year-over-year. Net income attributable to shareholders was $12.3 million, or $0.25 per share, compared to a loss of $15.1 million, or $0.31 per share, last year. Adjusted EPS totaled $0.35 for CRD-A and $0.36 […]

November 6, 2023 1 min read

Crawford & Company (NYSE: CRD-A, CRD-B) reported revenues before reimbursements of $325.6 million for the third quarter of 2023, up 10% year-over-year.

Net income attributable to shareholders was $12.3 million, or $0.25 per share, compared to a loss of $15.1 million, or $0.31 per share, last year. Adjusted EPS totaled $0.35 for CRD-A and $0.36 for CRD-B.

Consolidated cash and cash equivalents as of September 30, 2023, totaled $49.2 million.

ADVERTISEMENT